Super Spectra
Lod
About Super Spectra
Super Specta develops electro-optic device for Alzheimer’s disease (AD) early detection & deterioration follow-up, by real-time imaging of AD’s Bio-markers at the CerebroSpinal Fluid (CSF). The company applies a resolving method by adding a wavelength-dependent filter to a Raman spectrometer's detection channel, allowing users to monitor distinct molecular components in power concentrations online. Super Spectra was established in 2014 in Lod, Israel
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Last round: Series Unknown (May 2020)
- Website: super-spectra.com
Industries & Categories
Health Care, Health Diagnostics, Medical, Medical Device
Canonical: https://fsome.com/organization/super-spectra-1869907 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.